Cellular immunotherapy for refractory hematological malignancies.
Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ.
Reagan JL, et al.
J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150.
J Transl Med. 2013.
PMID: 23782682
Free PMC article.
Clinical Trial.